BA
The Boeing Company
BA has the edge over JBLU overall, supported by stronger fundamentals and lower modeled downside.
JBLU
JetBlue Airways Corporation
JBLU offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
JBLU Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Under pressure | |
| Weak |
JBLU's revenue is currently healthy, but its profitability, cash flow and balance sheet are under pressure.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | — |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA's PE is 18x, but its earnings don't support one, so it isn't a reliable read right now.
JBLU PE Valuation
JBLU has no meaningful PE right now: it lost money over the past year.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect BA to return to profit, with revenue growing. However, they disagree widely on these estimates.
JBLU Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect JBLU's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has the edge over JBLU on earnings quality, reporting a profit while its opponent remains loss making.
JBLU Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.67 | -$1.39 |
| Q2 2026 | -$2.38 | -$1.32 |
| Q1 2026 | -$1.93 | -$1.15 |
| Q4 2025 | -$1.66 | +$0.64 |
| Q3 2025 | -$1.28 | +$1.23 |
| Q2 2025 | -$1.06 | +$1.74 |
| Q1 2025 | -$0.78 | +$1.68 |
| Q4 2024 | -$2.30 | -$1.37 |
JBLU lost $2.67 per share over the past year, and its loss has widened in each of the last six quarters.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
BA has the edge over JBLU on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA has the edge over JBLU on profitability, with a higher operating margin.
JBLU Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.8B | +21% |
| Q2 2026 | $2.7B | +14% |
| Q1 2026 | $2.2B | +4.7% |
| Q4 2025 | $2.2B | -1.4% |
| Q3 2025 | $2.3B | -1.8% |
| Q2 2025 | $2.4B | -3% |
| Q1 2025 | $2.1B | -3.1% |
| Q4 2024 | $2.3B | -2.1% |
JBLU's revenue has picked up after three years of holding roughly level: $2.8B last quarter, up 21% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -5.1% | -0.8 points |
| Q2 2026 | -5.2% | -5.5 points |
| Q1 2026 | -10% | -1.9 points |
| Q4 2025 | -4.5% | -5.2 points |
| Q3 2025 | -4.3% | -2.7 points |
| Q2 2025 | 0.3% | -2.1 points |
| Q1 2025 | -8.1% | +24 points |
| Q4 2024 | 0.7% | +3.6 points |
JBLU's operating margin was −5.1% last quarter, down 0.8 points from the same quarter a year ago.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
BA has the edge over JBLU on cash generation, producing positive trailing cash flow while its opponent burns cash.
JBLU Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$465M | -$54M |
| Q2 2026 | -$377M | +$35M |
| Q1 2026 | -$6M | +$56M |
| Q4 2025 | -$287M | +$81M |
| Q3 2025 | -$411M | -$109M |
| Q2 2025 | -$412M | +$29M |
| Q1 2025 | -$62M | +$161M |
| Q4 2024 | -$368M | +$96M |
JBLU has burned cash in almost every quarter: −$1.1B over the past year, against −$1.3B the year before.
BA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +2.1M shares |
| 1 year | +4.3% | +32.8M shares |
| 3 years | +31% | +186M shares |
| 5 years | +35% | +204M shares |
| Available history | +40% | +227M shares |
BA has 793M diluted shares, up 4.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
JBLU Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.4M shares |
| 1 year | +3.7% | +13.6M shares |
| 3 years | +13% | +44M shares |
| 5 years | +17% | +56M shares |
| Available history | +26% | +78.9M shares |
JBLU has the edge over BA on shareholder dilution, with a more favorable share count trend.
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA has the edge over JBLU on leverage, with a lower net debt burden relative to earnings.
JBLU Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 62.0x | High |
| Q2 2026 | 46.7x | High |
| Q1 2026 | 23.4x | High |
| Q4 2025 | 20.5x | High |
| Q3 2025 | 14.2x | High |
| Q2 2025 | 13.1x | High |
| Q1 2025 | 11.8x | High |
| Q4 2023 | 9.1x | High |
JBLU's net debt is more than 20 years of its operating earnings (EBITDA), up from 14 years a year ago.
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
JBLU Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.6 | Neutral |
| Stochastic | 30.8 | Neutral |
JBLU's weekly RSI is 44 (neutral) and its Stochastic is 31 (neutral).
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA is trading at 18x earnings, a 26% discount to the Industrials sector's median of 24x, though its earnings don't support one.
JBLU PE vs Industrials Sector
| Metric | JBLU | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | — |
JBLU has no meaningful PE right now: it lost money over the past year.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
JBLU Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% above |
| 20 week MA | $4.58 | 17% below |
| 50 week MA | $4.88 | 22% below |
| 100 week MA | $5.06 | 25% below |
| 200 week MA | $5.70 | 33% below |
JBLU has the edge over BA on trend strength, trading above more of its moving averages.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has finished lower in four of the last six years. It's down 21% so far in 2026.
JBLU Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $18.9 | $14.4 | -24% |
| 2021 | $14.4 | $14.7 | +1.7% |
| 2022 | $14.7 | $6.45 | -56% |
| 2023 | $6.45 | $5.55 | -14% |
| 2024 | $5.55 | $7.80 | +41% |
| 2025 | $7.80 | $4.69 | -40% |
| 2026 YTD | $4.69 | $3.81 | -19% |
JBLU has the edge over BA on returns for 2026, with the stronger performance.